The Edit · Founder Insights
Singaporeans live to 84 but spend ~10 years in poor health. Strength training is the single most effective intervention to close that gap. Here's the evidence.
Singapore's life expectancy is 84.8 years, one of the highest in the world. Healthy life expectancy is 73.6. That gap of roughly 11 years — over a decade per Singaporean spent managing chronic disease, recovering from falls, or losing independence — is the hidden cost of an ageing society. By 2030, one in four Singaporeans will be 65 or older. The single most effective intervention to compress that gap is structured strength training, started decades earlier than most people start it.
TL;DR
- Singapore's life expectancy is 84.8 years; healthy life expectancy is 73.6. The 11-year gap is years lived with significant health limitations.
- Singapore is ageing faster than almost any country on Earth: from 13% over-65 in 2015 to nearly 25% projected by 2030.
- The chronic disease burden is already heavy — 1 in 3 adults has hypertension or hyperlipidaemia. Insufficient physical activity is the biggest modifiable driver.
- Sarcopenia (age-related muscle loss) affects 32% of Singaporeans over 60 and is the engine of frailty, falls, and loss of independence.
- The intervention is unambiguous: progressive resistance training two to three times per week. Singapore's 2022 Clinical Practice Guidelines endorse it as first-line.
The numbers behind the Singapore ageing problem
Singapore is one of the most rapidly ageing societies in Asia. In 2015, 13.1% of citizens were aged 65 and above. By 2025, that figure had jumped to 20.7% — a 60% increase in 10 years. By 2030, around one in four citizens will be 65 or older. The pace is sharper than nearly any country has experienced in peacetime.
This demographic shift collides with a chronic-disease burden that is already substantial. According to Ministry of Health data, roughly 1 in 3 Singapore residents has hypertension or hyperlipidaemia. Diabetes prevalence remains stubbornly high. The MOH has identified insufficient physical activity as one of the key modifiable risk factors driving these conditions.
The healthy life expectancy gap is the part of the picture that doesn't make policy headlines. Life expectancy at birth: 84.8 years. Healthy life expectancy: 73.6 years. The 11-year delta is the years a typical Singaporean spends with disability, dependence, or chronic illness. That decade is what we are training to compress.
Sarcopenia, the silent epidemic underneath the chronic disease headlines
Sarcopenia is the progressive, age-related loss of skeletal muscle mass and function. It is not a dramatic clinical event. It happens gradually, often unnoticed, over years. By the time most people realise it is happening, the damage is significant.
Sarcopenia affects 32% of Singaporeans over 60, per the Yishun Study published in JAMDA in 2021. Prevalence rises sharply in clinical settings: studies of post-acute hospital patients in Singapore have found prevalence exceeding 50%. Sarcopenia is what brings older Singaporeans into hospitals, and what keeps them there.
The clinical consequences are not marginal. Sarcopenia roughly doubles all-cause mortality risk, with a hazard ratio rising to 2.84 in adults over 80 in residential care. It raises fall risk by approximately 50% overall. It is the engine of frailty, the predictor of disability, and the strongest single driver of the loss-of-independence trajectory that defines unhealthy ageing.
The good news: sarcopenia is reversible. Singapore's 2022 Clinical Practice Guidelines for Sarcopenia endorse progressive resistance training as first-line treatment. The diagnostic infrastructure — calf circumference screening, handgrip dynamometry, AWGS 2019 thresholds — is in place. What's missing for most adults is starting the intervention before the diagnostic threshold is crossed.
Why strength training is the most effective lever
Of every intervention available to compress the healthspan gap, structured progressive resistance training has the strongest trial evidence. It directly addresses the muscle mass and strength loss that drives sarcopenia. It indirectly protects cardiovascular health, metabolic health, bone density, and balance. It is the only intervention that simultaneously addresses all four pillars of the Catalyst Healthspan Assessment: body composition, cardiorespiratory fitness, stability, and strength.
The dose is unglamorous. Two to three sessions per week, around three total hours, captures most of the available gain. The work is compound lifts (squats, hip hinges, presses, pulls, carries) at moderate-to-high intensity, with progressive load. Recovery is not training; sleep, protein, and walking are the inputs that close the loop.
Time-to-effect is shorter than most people expect. Strength gains begin within 4 weeks. Functional gains (chair stand, gait speed, balance) become clinically meaningful within 12-16 weeks. The Catalyst studio's 16-week Checkpoint cadence is calibrated to match this — long enough to see real adaptation, short enough to recalibrate before the prescription drifts off-target.
The decade you spend in disability at the end of life is decided in the decade you spend in your 50s. Train accordingly.
What changes about training after 40, 50, and 60
The prescription doesn't change with age. The execution does. The dose — two or three sessions per week, compound lifts, progressive overload — works at every age. What changes is the ramp, the load progression rate, the recovery time between sessions, and the technical complexity of the movements.
40s. The biggest decision is starting. Recovery is still robust, work capacity is still high, and the muscle-building response is mostly intact. The window for getting in front of the curve is widest here. Most adults who start at 40 with a structured programme are stronger at 60 than they were at 40.
50s. Anabolic resistance starts to set in. Older muscle responds less efficiently to a given protein bolus and a given training stimulus. The fix is volume and consistency, not intensity. Add a deload week every 4-6 weeks. Prioritise sleep. Eat enough protein. The training prescription is the same; the support around it tightens.
60s and beyond. Movement quality matters more than load. Most older adults benefit from starting with machine-based work for technical safety before progressing to free weights. The first six to eight weeks at Catalyst's seniors programme typically use a Keiser-led protocol for that reason — the equipment constrains movement path and lowers technical demand. The trial evidence on resistance training in adults aged 80+ is unambiguous: even at that age, the muscle and strength response is real and meaningful.
The prescription, regardless of where you start
Two to three structured strength sessions per week, hitting compound movement patterns at moderate-to-high intensity. Zone 2 cardiovascular work for 90-180 minutes per week (any conversational-pace activity counts: walking, cycling, swimming). One or two short high-intensity intervals per week. Stability and mobility woven through both. Total dedicated training time: under three hours per week.
Singapore's training infrastructure has caught up. The Health Promotion Board's National Steps Challenge encourages baseline activity. Polyclinics are screening more aggressively for chronic disease. Geriatric medicine has clear guidelines for sarcopenia management. The remaining gap is between policy and practice — between the population-level guidelines and the individual decision to start.
If you are reading this in your 30s or 40s, the 11-year healthspan gap is your retirement. Whether that gap stays at 11 years or compresses to 5 is decided by what you do every Tuesday at 7am, sustained over the next two decades. The intervention is well-evidenced, time-efficient, and accessible. The hard part isn't the protocol — it's the consistency.
Frequently asked questions
Q. What is the average lifespan in Singapore?
Life expectancy at birth in Singapore is approximately 84.8 years (latest national data), among the highest globally. Healthy life expectancy — the years lived without significant disability or chronic disease — is roughly 73.6 years. The gap of approximately 11 years represents the period most Singaporeans spend with reduced functional independence at the end of life.
Q. What percentage of Singapore is over 65?
As of 2025, around 20.7% of Singaporean citizens are aged 65 or older. By 2030 the figure is projected to reach approximately 24% — roughly one in four. The trajectory is sharper than almost any other country has experienced.
Q. What is the most important thing for healthy ageing in Singapore?
The strongest single intervention with trial-grade evidence is structured progressive resistance training, two to three times per week. It directly addresses sarcopenia (muscle loss) — the underlying driver of late-life frailty and dependence — and indirectly protects cardiovascular, metabolic, and bone health. Singapore's 2022 Clinical Practice Guidelines endorse it as first-line for sarcopenia.
Q. When should I start training for healthy ageing?
Earlier is better, but the intervention works at every age. Adults who start in their 30s and 40s have the widest window for getting ahead of the curve. Adults who start in their 60s and 70s still see meaningful gains within 12-16 weeks. The trial evidence on resistance training in adults aged 80+ shows real strength and function improvement.
Q. Is walking enough exercise for healthy ageing in Singapore?
No, walking alone does not address sarcopenia. Walking is excellent for cardiovascular health, mood, and Zone 2 cardiorespiratory fitness, but it does not provide the mechanical load required to build or preserve muscle mass. The trial evidence is unambiguous: structured resistance training is required to address the muscle-loss component of unhealthy ageing.
Citations
Singapore Department of Statistics, National Population and Talent Division. Population trends and projections. population.gov.sg
Pang BWJ, Wee SL, Lau LK, et al. (2021). Prevalence and Associated Factors of Sarcopenia in Singaporean Adults: The Yishun Study. Journal of the American Medical Directors Association, 22(4), 885.e1–885.e10. pubmed.ncbi.nlm.nih.gov
Lim WS, Cheong CY, Lim JP, et al. (2022). Singapore Clinical Practice Guidelines for Sarcopenia. The Journal of Frailty & Aging, 11(4), 348–369. springer.com
Xu J, Wan CS, Ktoris K, et al. (2022). Sarcopenia Is Associated with Mortality in Adults: A Systematic Review and Meta-Analysis. Gerontology, 68(4), 361–376. karger.com
Singapore Ministry of Health. National Population Health Survey 2022 Report. moh.gov.sg
